These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11281748)

  • 1. Adherence to protease inhibitors.
    Murri R; Ammassari A; Antinori A
    Ann Intern Med; 2001 Apr; 134(7):625. PubMed ID: 11281748
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-resistant genotyping in HIV-1 therapy.
    Spire B; Souville M
    Lancet; 1999 Sep; 354(9184):1121. PubMed ID: 10509524
    [No Abstract]   [Full Text] [Related]  

  • 3. [Discontinuation of antiretroviral treatment containing a protease inhibitor. Failure and tolerance].
    Michelet C
    Presse Med; 1999 Feb; 28(8):402-4. PubMed ID: 10093600
    [No Abstract]   [Full Text] [Related]  

  • 4. British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy.
    Pozniak A; Gazzard B; Anderson J; Babiker A; Churchill D; Collins S; Fisher M; Johnson M; Khoo S; Leen C; Loveday C; Moyle G; Nelson M; Peter B; Phillips A; Pillay D; Wilkins E; Williams I; Youle M;
    HIV Med; 2003 Oct; 4 Suppl 1():1-41. PubMed ID: 14511246
    [No Abstract]   [Full Text] [Related]  

  • 5. Medication adherence in patients with HIV infection: a comparison of two measurement methods.
    Melbourne KM; Geletko SM; Brown SL; Willey-Lessne C; Chase S; Fisher A
    AIDS Read; 1999 Aug; 9(5):329-38. PubMed ID: 12737122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Principles of treating HIV.
    Johnson D
    S Afr Med J; 2000 Mar; 90(3):227-30. PubMed ID: 10853393
    [No Abstract]   [Full Text] [Related]  

  • 7. Glucose tolerance in HIV-1 treated patients who switched from boosted-protease inhibitors to etravirine.
    Carbone A; Bigoloni A; Galli L; Spagnuolo V; Gianotti N; Lazzarin A; Castagna A
    AIDS; 2013 Oct; 27(16):2661-3. PubMed ID: 24096632
    [No Abstract]   [Full Text] [Related]  

  • 8. Preclinical data released on PI.
    AIDS Patient Care STDS; 2003 Sep; 17(9):483-4. PubMed ID: 14596252
    [No Abstract]   [Full Text] [Related]  

  • 9. Resistance data on 908.
    AIDS Patient Care STDS; 2003 Sep; 17(9):483. PubMed ID: 14588086
    [No Abstract]   [Full Text] [Related]  

  • 10. What is the relevance of antiretroviral therapy that does not include protease inhibitors?
    Miller LG; Goetz MB
    Clin Infect Dis; 1998 Dec; 27(6):1386-7. PubMed ID: 9868647
    [No Abstract]   [Full Text] [Related]  

  • 11. New combinations of drug therapies for the treatment of the human immunodeficiency virus (HIV).
    J Am Osteopath Assoc; 1996 Aug; 96(8):450. PubMed ID: 8810154
    [No Abstract]   [Full Text] [Related]  

  • 12. Virologic outcome and predictors of virologic failure of highly active antiretroviral therapy containing protease inhibitors.
    Knobel H; Guelar A; Carmona A; Espona M; González A; López-Colomés JL; Saballs P; Gimeno JL; Díez A
    AIDS Patient Care STDS; 2001 Apr; 15(4):193-9. PubMed ID: 11359661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced levels of CD4 cell spontaneous apoptosis in human immunodeficiency virus-infected patients with discordant response to protease inhibitors.
    Meroni L; Varchetta S; Manganaro D; Gatti N; Riva A; Monforte Ad; Galli M
    J Infect Dis; 2002 Jul; 186(1):143-4. PubMed ID: 12089680
    [No Abstract]   [Full Text] [Related]  

  • 14. New developments in antiretroviral treatment.
    Sadovsky R
    Am Fam Physician; 1999 Dec; 60(9):2663, 2666. PubMed ID: 10605997
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination drug therapy for the human immunodeficiency virus (HIV).
    J Am Osteopath Assoc; 1997 Mar; 97(3):128. PubMed ID: 9107121
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiretroviral therapy for HIV infection. Heartening successes mixed with continuing challenges.
    Henry K; Stiffman M; Feldman J
    Postgrad Med; 1997 Oct; 102(4):100-7, 111-3, 119-20. PubMed ID: 9336600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART). Swiss HIV Cohort Study.
    Kaufmann D; Pantaleo G; Sudre P; Telenti A
    Lancet; 1998 Mar; 351(9104):723-4. PubMed ID: 9504519
    [No Abstract]   [Full Text] [Related]  

  • 18. Drugs for HIV infection.
    Haemophilia; 2000 Jul; 6 Suppl 1():79-83. PubMed ID: 10982272
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic implications of recent data on immune pathogenesis of HIV disease.
    Laurence J
    AIDS Patient Care STDS; 1999 Aug; 13(8):449-51. PubMed ID: 10800522
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug-resistant genotyping in HIV-1 therapy.
    Nannini E
    Lancet; 1999 Sep; 354(9184):1121. PubMed ID: 10509523
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.